Your browser doesn't support javascript.
loading
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.
Arai, Sally; Pidala, Joseph; Pusic, Iskra; Chai, Xiaoyu; Jaglowski, Samantha; Khera, Nandita; Palmer, Jeanne; Chen, George L; Jagasia, Madan H; Mayer, Sebastian A; Wood, William A; Green, Michael; Hyun, Teresa S; Inamoto, Yoshihiro; Storer, Barry E; Miklos, David B; Shulman, Howard M; Martin, Paul J; Sarantopoulos, Stefanie; Lee, Stephanie J; Flowers, Mary E D.
Afiliação
  • Arai S; Department of Medicine/Division of Blood and Marrow Transplant, Stanford University School of Medicine, Stanford, California.
  • Pidala J; Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Pusic I; Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine, St. Louis, Missouri.
  • Chai X; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Jaglowski S; Division of Hematology, Internal Medicine, Ohio State University, Columbus, Ohio.
  • Khera N; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Palmer J; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Chen GL; Department of Medicine/Division of Blood and Marrow Transplant, Stanford University School of Medicine, Stanford, California.
  • Jagasia MH; Department of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Mayer SA; Mayer Weill Cornell Medical College, New York, New York.
  • Wood WA; Department of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina.
  • Green M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke Cancer Institute, Duke University, Durham, North Carolina.
  • Hyun TS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Inamoto Y; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Storer BE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Miklos DB; Department of Medicine/Division of Blood and Marrow Transplant, Stanford University School of Medicine, Stanford, California.
  • Shulman HM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Martin PJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke Cancer Institute, Duke University, Durham, North Carolina.
  • Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Flowers ME; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. mflowers@fhcrc.org.
Clin Cancer Res ; 22(2): 319-27, 2016 Jan 15.
Article em En | MEDLINE | ID: mdl-26378033
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose / Dermatopatias / Transplante de Células-Tronco Hematopoéticas / Mesilato de Imatinib / Rituximab / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose / Dermatopatias / Transplante de Células-Tronco Hematopoéticas / Mesilato de Imatinib / Rituximab / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article